Dr. Georg Schmolzer
Claim this profileRoyal Alexandra Hospital
Studies Cardiac Arrest
Studies Neonatal Respiratory Distress Syndrome
7 reported clinical trials
14 drugs studied
Affiliated Hospitals
Clinical Trials Georg Schmolzer is currently running
Oxygen Levels at Birth
for Low Birth Weight Infants
Preterm birth, or birth before 37 weeks' gestation, is increasingly common, occurring in 8 percent of pregnancies in Canada. Preterm birth is associated with many health complications, particularly when the birth happens before 29 weeks' gestation. At this gestational age, the lungs are not fully developed and it is not uncommon for infants to have problems breathing at the time of birth. One complication that can arise is when an infant stops breathing and needs to be resuscitated. When preterm babies need to be resuscitated doctors must take special care because of the small infant size and the immaturity of the brain and lungs. Oxygen is used to resuscitate babies who need it, but unfortunately there is disagreement about the best oxygen concentration to use. Oxygen concentration is important because both too much and too little oxygen can cause brain injury. This research aims to fill this knowledge gap by participating in an international clinical trial to compare the effects of resuscitating babies less than 29 weeks' gestational age with either a low oxygen concentration or a high oxygen concentration. The oxygen concentrations have been selected using the best available knowledge. This will be a cluster randomized trial where each participating hospital will be randomized to either 30 or 60 percent oxygen for the recruitment of 30 infants, and afterwards randomized to the other group for the recruitment of another 30 infants. After the trial, the investigator will determine whether the babies resuscitated with low oxygen or those resuscitated with high oxygen have better survival and long-term health outcomes. This research fills a critical knowledge gap in the care of extremely preterm babies and will impact their survival both here in Canada and internationally.
Recruiting1 award N/A1 criteria
Vasopressin vs. Epinephrine
for Neonatal Cardiac Arrest
When a baby is born with a low heart rate or no heart rate, the clinical team must provide breathing support and chest compressions (what is call cardiopulmonary resuscitation or CPR). In some situations, the clinical team also need to give medications to help the heart rate increase. During CPR, the most common medication given is called epinephrine. There is another medication called vasopressin that is available that could be beneficial to newborn babies. However, no study has compared epinephrine with vasopressin in the delivery room during neonatal CPR. The current study will be the first trial comparing this two medications during neonatal CPR. The investigators will randomize our hospital to either epinephrine or vasopressin for the duration of one year. Babies will either receive CPR with epinephrine (this will be the control group) or CPR with vasopressin ( this will be the intervention group). The investigators believe that vasopressin may be more helpful to babies with a low heartrate or no heart rate at birth.
Recruiting1 award Phase 11 criteria
More about Georg Schmolzer
Clinical Trial Related2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Georg Schmolzer has experience with
- 3:1 C:V
- CC+SI
- Intervention (21% Oxygen During CC+SI)
- Intervention (100% Oxygen During CC+SI)
- Volume Targeted Ventilation
- Pressure Targeted Ventilation
Breakdown of trials Georg Schmolzer has run
Cardiac Arrest
Neonatal Respiratory Distress Syndrome
Respiratory Distress Syndrome
Slow Heart Rate
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Georg Schmolzer specialize in?
Georg Schmolzer focuses on Cardiac Arrest and Neonatal Respiratory Distress Syndrome. In particular, much of their work with Cardiac Arrest has involved treating patients, or patients who are undergoing treatment.
Is Georg Schmolzer currently recruiting for clinical trials?
Yes, Georg Schmolzer is currently recruiting for 3 clinical trials in Edmonton Alberta. If you're interested in participating, you should apply.
Are there any treatments that Georg Schmolzer has studied deeply?
Yes, Georg Schmolzer has studied treatments such as 3:1 C:V, CC+SI, Intervention (21% oxygen during CC+SI).
What is the best way to schedule an appointment with Georg Schmolzer?
Apply for one of the trials that Georg Schmolzer is conducting.
What is the office address of Georg Schmolzer?
The office of Georg Schmolzer is located at: Royal Alexandra Hospital, Edmonton, Alberta T5H 3V9 Canada. This is the address for their practice at the Royal Alexandra Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.